Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates

Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates

Schizophrenia is a severe neuropsychiatric disorder that affects approximately 0.5–1% of the population. Response to antipsychotic therapy is highly variable, and it is not currently possible to predict those patients who will or will not respond to antipsychotic medication. Furthermore, a high perc...

Full description

Bibliographic Details
Main Authors: Antonio Vita, Alessandra Minelli, Stefano Barlati, Giacomo Deste, Edoardo Giacopuzzi, Paolo Valsecchi, Cesare Turrina, Massimo Gennarelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
treatment resistant schizophrenia (TRS)
genetic
pharmacogenetic
pharmacogenomic
neuroimaging
precision medicine
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00402/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00402/full

Similar Items